Althoughglipizideadd-onwasassociatedwithlargerinitial reductionsinFPGfrombaselinethandapagliflozinduringthe first 26weeks, reductions were sustained in the dapagliflozin arm compared with the glipizide arm at each time point assessed,untilweek208[−0.7mmol/L(95%CI−1.0,−0.5)vs −0.2mmol/L (95% CI −0.5, 0.1)] from baseline to study end, FigureS3.